STERIS labs expands services with maldi-tof identification in brooklyn park, MN

February 13, 2019

STERIS Laboratories is pleased to announce that our new MALDI-ToF (Matrix Assisted Laser Desorption/Ionization with Time of Flight) system has been fully validated at our Brooklyn Park, Minnesota, USA lab and is now available for Customers of the laboratory to use.

The MALDI-ToF method of identification provides rapid microbial identification and reduces the requirements and risk of performing repeat tests.

This investment has been undertaken in response to regulatory changes that require Customers to perform identification testing of micro-organisms and is the second machine following the one installed at our Tullamore, Ireland laboratory in 2017.

As outlined in ISO 11137, both the number and type of micro-organisms must be identified during sterilization validation, and this state-of-the-art equipment provides a rapid and actionable identification service.

The MALDI-ToF identification service is also available to Customers of our Libertyville, Illinois laboratory, with testing seamlessly managed through our local operational teams.

For more information on our MALDI-ToF system, or any other laboratory testing services, please email us at labs_info@steris.com or contact your STERIS Account Manager.

STERIS labs expands services with maldi-tof identification in brooklyn park, MN

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. 

For more information, visit www.steris.com.

 
Related Posts
STERIS Venlo, NL Facility
October 8, 2026
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completion of the expansion of its existing Venlo, The Netherlands ethylene oxide and X-ray processing facility to include a second X-ray processing line. 
STERIS Alajuela, Costa Rica
September 29, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of the laboratory testing capabilities available at our facility in Alajuela, Costa Rica.

STERIS Ede, The Netherlands Laboratory
September 28, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce that the Ede, The Netherlands laboratory has achieved ISO 17025 accreditation.

Montreal Opening Announcement
August 24, 2026

As part of our commitment to ensuring patient and consumer safety, STERIS is pleased to announce the competition of a new electron beam (E-beam) processing facility in Montreal, Canada.